Boehringer Ingelheim has signed a €500m ($572m) agreement with UK-based biotech Tessellate Bio to co-develop targeted cancer ...

The expiration of the FDA’s paediatric priority review voucher programme is creating uncertainty for rare disease drug ...

EditCo Bio has entered a licensing agreement to secure access to Promega’s protein-tagging and bioluminescent identification ...

Swiss oncology firm Veraxa Biotech is set to go public in the US through a merger with Voyager Acquisition Corp, a healthcare ...

Contraception for women has seen little change over the past 50 years, with the most prevalent contraceptive pills containing ...

ConcertAI has announced an agreement with Bayer that allows the latter to utilise its Translational360 and AI SaaS solutions.

Mochi Health, one of those implicated, is one of the largest telehealth providers of compounded GLP-1RAs. Eli Lilly maintains ...

TNF and Renova Health are set to use AI and ML for the identification of high-risk subjects who could benefit from GLP-1 ...

Roche is set to invest $50bn in pharmaceuticals and diagnostics in the US over the coming five years to bolster its presence ...

The public cash offer, via a newly formed company by KKR called RWK BidCo, is for Skr145 per share in Biotage. The offer, ...

To meet growing demands amid an increasingly challenging industry landscape, a critical decision for a CRO is to ensure ...

Regeneron Pharmaceuticals has entered a new manufacturing and supply agreement with Fujifilm Diosynth Biotechnologies.